Genomic health, inc (GHDX)
Balance Sheet / TTM
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
ASSETS
Current assets:
Cash and cash equivalents

71,961

90,925

101,406

61,645

69,242

53,847

42,085

45,518

43,019

42,200

40,774

40,404

33,999

40,660

30,705

32,533

28,010

23,751

22,938

29,726

37,238

32,494

28,241

33,279

39,781

32,822

17,097

18,005

57,959

57,014

36,991

32,869

38,281

23,750

31,183

Short-term marketable securities

203,474

152,625

104,551

148,149

114,021

99,098

88,302

84,057

75,942

67,599

53,648

56,585

64,602

52,894

55,671

62,410

70,003

95,912

105,042

73,934

67,452

73,209

72,621

72,071

74,265

74,428

78,980

81,060

68,251

55,570

64,854

67,605

40,278

37,252

45,635

Accounts receivable

55,875

54,307

59,248

51,531

51,553

48,982

46,567

31,161

35,584

32,427

34,593

35,179

33,682

33,611

38,829

37,164

33,754

32,900

34,979

34,916

30,967

31,771

28,901

29,446

25,594

26,690

27,045

22,253

19,926

21,699

20,837

21,077

22,646

19,369

14,306

Prepaid expenses and other current assets

13,726

14,369

15,446

13,511

11,886

13,449

14,035

13,524

11,506

12,278

13,079

13,796

12,066

11,852

11,352

10,843

10,238

9,830

12,085

9,944

9,551

9,014

10,125

10,196

9,314

8,781

9,517

8,891

8,630

8,206

7,763

7,444

7,040

6,980

6,541

Total current assets

345,036

312,226

280,651

274,836

246,702

215,376

190,989

174,260

166,051

154,504

142,094

145,964

144,349

139,017

136,557

142,950

142,005

162,393

175,044

148,520

145,208

146,488

139,888

144,992

148,954

142,721

132,639

130,209

154,766

142,489

130,445

128,995

108,245

87,351

97,665

Property and equipment, net

46,491

43,098

39,913

39,532

39,804

40,054

40,824

46,440

47,411

48,908

49,459

45,688

39,465

39,052

39,311

39,746

34,682

28,560

25,171

21,860

18,099

17,342

18,065

18,290

18,242

15,468

14,834

14,104

11,799

10,276

10,304

9,443

9,551

9,591

10,345

Operating lease right-of-use assets

50,082

51,926

53,295

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term marketable securities

-

-

-

4,066

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,285

-

-

-

-

-

771

1,291

1,299

-

8,835

19,914

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

113

121

-

Other assets

18,802

18,913

18,931

15,938

13,860

13,586

11,126

10,917

9,522

9,518

10,321

9,462

8,137

2,020

1,853

1,921

1,656

1,572

1,755

15,541

16,038

14,120

14,099

13,752

9,504

9,468

9,527

9,421

5,837

4,923

4,533

4,560

4,335

4,395

2,851

Total assets

460,411

426,163

392,790

334,372

300,366

269,016

242,939

231,617

222,984

212,930

201,874

201,114

191,951

180,089

177,721

184,617

178,343

192,525

201,970

185,921

179,345

177,950

173,337

177,034

176,700

167,657

157,000

153,734

173,173

158,979

146,581

142,998

131,079

121,372

110,861

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable

6,431

6,683

9,290

8,849

6,545

5,192

4,744

156

8,475

5,322

5,238

2,864

5,411

4,796

4,702

8,585

5,595

5,961

7,952

6,987

5,895

5,560

7,562

5,160

3,545

3,693

3,983

4,881

3,392

3,489

3,226

7,025

2,722

1,895

3,968

Accrued compensation and employee benefits

31,934

26,091

22,039

34,457

29,132

21,750

21,913

24,953

24,619

21,355

19,109

27,900

24,675

20,514

20,058

22,239

20,804

17,998

16,388

17,708

13,426

14,213

11,399

13,884

11,190

12,003

9,378

11,210

9,636

9,881

8,279

9,574

8,433

8,244

7,352

Accrued license fees

-

-

-

-

-

-

-

-

-

-

-

-

-

2,334

2,495

2,287

2,197

2,077

2,249

2,656

2,465

2,313

2,300

2,554

2,319

2,227

2,076

2,292

2,082

1,889

1,945

1,947

2,899

2,716

3,126

Accrued expenses and other current liabilities

14,743

16,888

13,404

15,870

14,303

12,705

11,648

14,084

11,116

12,185

12,137

10,180

13,599

11,140

9,599

8,922

14,465

12,406

15,510

10,444

11,403

9,863

9,958

7,356

10,451

8,340

8,773

6,340

8,122

5,765

7,024

5,501

6,708

5,203

5,584

Current portion of operating lease liabilities

4,530

4,442

4,495

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenues

-

-

-

-

-

-

-

-

-

-

-

-

28

235

374

431

251

524

268

335

189

273

8

586

1,134

278

53

374

800

1,403

1,250

1,407

1,284

1,441

1,295

Other current liabilities

262

260

258

600

425

340

343

323

212

222

281

231

231

208

208

208

208

208

208

208

209

192

192

292

292

243

243

243

93

93

93

685

282

-

243

Total current liabilities

57,900

54,364

49,486

59,776

50,405

39,987

38,648

39,516

44,422

39,084

36,765

41,175

43,944

39,227

37,436

42,672

43,520

39,174

42,575

38,338

33,587

32,414

31,419

29,832

28,931

26,784

24,506

25,340

24,125

22,520

21,817

26,139

22,328

19,499

21,568

Operating lease liabilities

50,786

52,423

53,482

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenues-long-term portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

211

504

737

1,526

Other liabilities

2,352

2,155

1,941

4,436

3,944

3,826

3,899

3,810

3,867

3,899

3,941

3,834

3,606

2,306

2,874

2,410

2,294

2,982

2,667

2,070

2,130

2,083

2,136

2,221

2,141

1,897

1,915

2,068

2,211

2,205

2,199

1,289

1,356

1,471

1,657

Commitments and contingencies

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders' equity:
Preferred stock, $0.0001 par value, 5,000,000 shares authorized, no shares issued and outstanding

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

0

-

-

0

Common stock

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

3

Additional paid-in capital

538,083

524,551

511,265

506,679

491,409

482,835

466,424

464,637

452,653

445,713

434,191

427,102

415,144

408,516

397,337

395,059

386,738

382,039

373,674

370,496

362,331

355,889

347,582

345,345

336,617

330,451

319,048

313,915

306,289

297,437

287,499

281,147

275,250

271,179

259,724

Accumulated other comprehensive income (loss)

42

116

49

-87

-50

-65

-148

-294

-27

-26

-22

1,198

2,804

767

4,701

2,752

1,332

12,028

17,515

-15

-2

3

21

12

18

21

33

15

16

-2

47

-30

-42

28

-10

Accumulated deficit

-188,755

-207,449

-193,326

-206,325

-215,235

-227,460

-235,777

-245,945

-247,824

-245,633

-242,894

-242,088

-243,440

-240,620

-234,520

-228,169

-225,434

-213,591

-204,354

-194,861

-188,594

-182,332

-177,714

-170,269

-160,900

-161,389

-158,395

-157,512

-159,471

-163,184

-164,984

-165,761

-168,320

-171,545

-173,607

Treasury stock, at cost

-

-

30,110

30,110

30,110

30,110

30,110

30,110

30,110

30,110

30,110

30,110

30,110

30,110

30,110

30,110

30,110

30,110

30,110

30,110

30,110

30,110

30,110

30,110

30,110

30,110

30,110

30,095

-

-

-

-

-

-

-

Total stockholders' equity

349,373

317,221

287,881

270,160

246,017

225,203

200,392

188,291

174,695

169,947

161,168

156,105

144,401

138,556

137,411

139,535

132,529

150,369

156,728

145,513

143,628

143,453

139,782

144,981

145,628

138,976

130,579

126,326

146,837

134,254

122,565

115,359

106,891

99,665

86,110

Total liabilities and stockholders' equity

460,411

426,163

392,790

334,372

300,366

269,016

242,939

231,617

222,984

212,930

201,874

201,114

191,951

180,089

177,721

184,617

178,343

192,525

201,970

185,921

179,345

177,950

173,337

177,034

176,700

167,657

157,000

153,734

173,173

158,979

146,581

142,998

131,079

121,372

110,861